Profile data is unavailable for this security.
About the company
Everest Medicines Ltd is a China-based company principally engaged in the licensing, clinical development and commercialization of therapies to address critical unmet medical needs. The Company is focusing on the research and development of innovative drug candidate. The Company built a portfolio of promising clinical-stage drug candidates across oncology, immunology, cardio-renal disease and infectious disease. The Company mainly provides its products and services in Greater China and other emerging Asia Pacific markets.
- Revenue in HKD (TTM)62.91k
- Net income in HKD-1.18bn
- Incorporated2017
- Employees405.00
- LocationEverest Medicines Ltd1266 West Nanjing RoadPlaza 66, Tower 1, Units 6601-6606SHANGHAI 200040ChinaCHN
- Websitehttp://www.everestmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peijia Medical Ltd | 159.05m | -668.93m | 4.32bn | 689.00 | -- | 1.22 | -- | 27.14 | -1.01 | -1.01 | 0.2404 | 5.24 | 0.0452 | 0.8946 | 4.55 | 230,848.50 | -19.00 | -- | -19.53 | -- | 70.06 | -- | -420.57 | -- | 19.88 | -23.51 | 0.0025 | -- | 253.21 | -- | 72.24 | -- | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 1.06bn | -684.58m | 4.34bn | 3.62k | -- | 0.6412 | -- | 4.08 | -0.778 | -0.778 | 1.21 | 7.69 | 0.0909 | 1.31 | 1.95 | 294,389.60 | -5.85 | 10.68 | -8.23 | 14.87 | 52.93 | 82.48 | -64.32 | 27.10 | 1.44 | -2.49 | 0.3466 | 38.26 | -61.08 | -0.5958 | -170.00 | -- | 27.36 | -- |
| VIVA Biotech Holdings | 2.45bn | 334.98m | 4.43bn | 2.13k | 23.77 | 0.9622 | 8.43 | 1.81 | 0.0964 | 0.0964 | 1.24 | 2.38 | 0.2598 | 7.33 | 5.66 | 1,152,394.00 | 3.71 | 2.39 | 4.14 | 2.63 | 30.94 | 37.43 | 14.28 | 10.18 | 1.89 | 4.53 | 0.4042 | 22.00 | 201.90 | 85.23 | 174.32 | 63.68 | 138.39 | -- |
| China Shineway Pharmaceutical Group Ltd. | 3.76bn | 648.49m | 4.87bn | 3.45k | 6.86 | 0.7085 | 5.66 | 1.30 | 0.8588 | 0.8588 | 4.97 | 8.31 | 0.4472 | 1.58 | 8.76 | -- | 7.72 | 6.69 | 9.18 | 7.75 | 74.77 | 72.83 | 17.27 | 17.68 | 4.65 | -- | 0.0025 | 49.62 | 21.38 | 10.09 | 88.68 | -1.13 | -- | 10.72 |
| SciClone Pharmaceuticals (Holdings) Ltd | 2.93bn | 1.08bn | 5.60bn | 890.00 | 5.24 | 2.04 | 4.66 | 1.91 | 1.56 | 1.56 | 4.22 | 4.02 | 0.7252 | 3.38 | 5.78 | 3,296,499.00 | 26.59 | -- | 40.14 | -- | 76.75 | -- | 36.66 | -- | 2.95 | 71.34 | 0.335 | -- | 31.27 | -- | 22.51 | -- | -- | -- |
| Frontage Holdings Corp | 1.45bn | 144.65m | 5.62bn | 1.32k | 39.64 | 2.21 | 16.72 | 3.88 | 0.0684 | 0.0684 | 0.6843 | 1.22 | 0.4297 | 141.01 | 6.49 | 1,095,122.00 | 4.41 | 6.98 | 5.14 | 8.28 | 36.16 | 37.31 | 10.26 | 13.51 | 2.88 | 10.88 | 0.1519 | 0.00 | 46.60 | 30.55 | 7.45 | 20.56 | 65.98 | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.40bn | 162.80m | 5.86bn | 1.86k | 36.01 | 1.30 | 21.16 | 1.09 | 0.0169 | 0.0169 | 0.5621 | 0.4686 | 0.4557 | 2.88 | 5.51 | 2,912,298.00 | 1.37 | 1.95 | 1.57 | 2.51 | 30.17 | 31.39 | 3.01 | 4.20 | 0.923 | 12.87 | 0.5799 | 48.48 | 9.30 | 2.10 | 30.00 | -8.44 | 0.6761 | 0.00 |
| CStone Pharmaceuticals | 1.30bn | -1.54bn | 5.99bn | 264.00 | -- | 2.19 | -- | 4.60 | -1.37 | -1.37 | 1.17 | 2.30 | 0.4281 | -- | -- | 5,274,235.00 | -50.67 | -- | -59.98 | -- | 75.62 | -- | -118.36 | -- | 5.63 | -4.57 | 0.0402 | -- | -- | -- | 40.98 | -- | -- | -- |
| Everest Medicines Ltd | 62.91k | -1.18bn | 6.07bn | 405.00 | -- | 0.8764 | -- | 96,485.41 | -4.01 | -4.01 | 0.0002 | 22.99 | 0.00001 | -- | 0.0035 | 155.33 | -14.28 | -- | -14.76 | -- | 57.41 | -- | -1,867,998.00 | -- | 9.94 | -- | 0.0799 | -- | -- | -- | 82.17 | -- | -- | -- |
| China Isotope & Radiation Corp | 5.99bn | 391.13m | 6.20bn | 3.12k | 15.85 | 1.27 | 6.12 | 1.03 | 1.22 | 1.22 | 18.73 | 15.22 | 0.5233 | 2.97 | 1.97 | 1,920,552.00 | 6.85 | 7.74 | 14.25 | 15.40 | 63.03 | 66.60 | 13.08 | 14.67 | 1.50 | -- | 0.1244 | 32.98 | 20.34 | 16.83 | 57.20 | 5.08 | 27.70 | -- |
| CARsgen Therapeutics Holdings Ltd | 30.07m | -5.53bn | 6.35bn | 573.00 | -- | 1.81 | -- | 211.19 | -23.67 | -23.67 | 0.0777 | 6.15 | -- | -- | -- | 52,479.45 | -- | -- | -- | -- | 100.00 | -- | -18,379.97 | -- | -- | -- | 0.1014 | -- | -- | -- | -345.88 | -- | -- | -- |
| Keymed Biosciences Inc | 128.46m | -4.53bn | 6.38bn | 325.00 | -- | 1.50 | -- | 49.65 | -21.54 | -21.54 | 0.7986 | 15.20 | -- | -- | -- | 395,253.30 | -- | -- | -- | -- | 84.40 | -- | -3,530.12 | -- | 31.81 | -800.03 | 0.0105 | -- | -- | -- | -374.88 | -- | -- | -- |
| Sirnaomics Ltd | 0.00 | -1.67bn | 6.80bn | 175.00 | -- | 4.05 | -- | -- | -91.17 | -91.17 | 0.00 | 18.86 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -296.44 | 0.0686 | -- | -- | -- | -386.77 | -- | -- | -- |
| New Horizon Health Ltd | 247.85m | -3.59bn | 6.96bn | 804.00 | -- | 2.81 | -- | 28.09 | -10.53 | -10.53 | 0.6548 | 5.76 | 0.1342 | 1.79 | 2.24 | 308,277.20 | -194.54 | -- | -218.67 | -- | 72.68 | -- | -1,450.14 | -- | 10.34 | -166.82 | 0.0547 | -- | 201.50 | -- | -291.18 | -- | -- | -- |
| Tong Ren Tang Technologies Co., Ltd. | 6.29bn | 590.92m | 7.43bn | 3.97k | 12.57 | 1.07 | 5.76 | 1.18 | 0.4614 | 0.4614 | 4.91 | 5.44 | 0.4793 | 1.11 | 4.83 | 1,586,301.00 | 7.69 | 8.75 | 12.92 | 13.79 | 42.43 | 46.27 | 16.05 | 17.79 | 2.15 | 31.36 | 0.1677 | 38.84 | 17.21 | 2.97 | 8.49 | -3.16 | -18.23 | -0.5399 |
| Ocumension Therapeutics | 65.41m | -302.88m | 7.87bn | 244.00 | -- | 2.17 | -- | 120.29 | -0.4947 | -0.4947 | 0.1077 | 5.43 | 0.0189 | 4.79 | 1.21 | 268,061.50 | -8.77 | -- | -9.25 | -- | 65.78 | -- | -463.06 | -- | 8.48 | -- | 0.0036 | -- | 328.73 | -- | 88.52 | -- | -- | -- |
Data as of May 27 2022. Currency figures normalised to Everest Medicines Ltd's reporting currency: Hong Kong Dollar HKD
23.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RA Capital Management LPas of 25 Jan 2022 | 24.25m | 8.05% |
| Janchor Partners Ltd.as of 31 Dec 2020 | 17.42m | 5.78% |
| Wellington Management Co. LLPas of 21 Mar 2022 | 13.88m | 4.61% |
| Janus Henderson Investors US LLCas of 31 Mar 2022 | 2.97m | 0.99% |
| GIC Pte Ltd. (Investment Management)as of 08 Oct 2020 | 2.82m | 0.94% |
| Candriam Belgium SAas of 31 Dec 2021 | 2.48m | 0.82% |
| The Vanguard Group, Inc.as of 05 May 2022 | 2.47m | 0.82% |
| BlackRock Advisors LLCas of 30 Apr 2022 | 2.06m | 0.69% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2021 | 1.94m | 0.64% |
| BlackRock Fund Advisorsas of 03 May 2022 | 1.58m | 0.53% |
More ▼
Data from 31 Mar 2022 - 19 May 2022Source: FactSet Research Systems Inc.
